Relay Therapeutics is trading 4.08% down at $19.73 in pre-market, with the reason for the decline unconfirmed.
- It closed at $20.57 on August 25, 2026; no clear company-specific overnight announcement, earnings release, regulatory action, or analyst change was identified.
- Broader futures are only modestly mixed, so macro sentiment does not clearly explain the move.
- Latest company results, released August 6, included approximately $911 million in cash, cash equivalents, and investments at quarter-end.